Purchase Order HHSN261201700537P
Award Date 8/22/17
Potential Completion Date 9/22/17
Potential Value $13K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Marshallton, DE 19808, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $18,781.20 on May 31, 2018, with an ultimate completion date of May 31, 2019. No set-aside was used. Performance takes place in Marshallton, Delaware. The order is for firm fixed price supply of analytical laboratory instruments and associated consumables from Agilent's Customer Service and Sales Division, a manufacturer of gas chromatography-mass spectrometry systems, liquid chromatography-mass...
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $24,998.51 in scientific laboratory equipment on March 11, 2021, with an ultimate completion date of May 31, 2021. Performance takes place in Marshallton, Delaware. The order is firm fixed price with no set-aside applied.</p>
- The National Cancer Institute issued a purchase order to Agilent Technologies Inc. on October 31, 2018, with a firm fixed price of $11,890.80 and an ultimate completion date of October 31, 2019. Place of performance is Marshallton, Delaware. The order procures analytical laboratory instrumentation or associated consumables and maintenance services, consistent with Agilent's core product portfolio of gas chromatography–mass spectrometry systems, liquid chromatography–mass spectrometry...
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,260.00 on August 31, 2020, for biological and reagent material with a firm fixed price. Place of performance is Marshallton, Delaware, with an ultimate completion date of September 30, 2020. The order was not set-aside and reflects full and open competition.</p>
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $10,972.00 on September 8, 2017, with ultimate completion on October 23, 2017. Performance took place in Marshallton, Delaware. The order was firm fixed price with no set-aside. The source does not specify the procurement's scope or originating solicitation.</p>
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for a reagent kit valued at $16,259.00 on August 26, 2019, with completion by September 18, 2019. Place of performance is Marshallton, Delaware. No set-aside was used. The order was issued on a firm fixed price basis for commercial laboratory consumables, consistent with Agilent's role as a supplier of analytical instrumentation and related supplies to federal research agencies.</p>
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,260.00 on November 9, 2020, for biological and reagent material. Place of performance is Marshtonlon, Delaware. The order carries a firm fixed price and an ultimate completion date of December 30, 2020.</p>
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $72,006.04 on September 17, 2018, for Artisan Link Pro laboratory instrumentation. Performance is located in Marshallton, Delaware, with an ultimate completion date of March 13, 2019. The procurement was issued under firm fixed price terms with no set-aside. The originating solicitation was posted August 22, 2018, with a due date of August 29, 2018.</p>
- <p>The National Cancer Institute issued a purchase order to Agilent Technologies Inc. on February 7, 2014, valued at $4,075.65, with completion by February 28, 2015. Performance occurs at Marshallton, Delaware. The order carries no set-aside designation and uses firm fixed pricing.</p>
- <p>The National Cancer Institute issued a delivery order to Agilent Technologies Inc. on August 23, 2018, with a ceiling value of $39,684.59 for a high-pressure liquid chromatography system for separation and analyses of radiolabeled chemicals.</p> <p>Place of performance is Marshallton, Delaware. The order is firm fixed price with an ultimate completion date of October 2, 2018. No set-aside was used.</p>